Peptides in this program address age-related eye regeneration, optic nerve regeneration, cataracts, diabetic retinopathy, eye floaters, near and farsightedness, and macular degeneration.
NOTE: This program can be a first selection with the intention to follow with the Peptide Detox and the Deep Detox programs. Vision Repair and Deep Detox Programs may be done simultaneously.
Vision Repair Peptide Program
Age-Related Eye Regeneration
Age-Related Eye Regeneration addresses neuroprotective, anti-oxidative, anti-inflammatory, and adhesive mechanisms to preserve photoreceptors, retinal pigment epithelium (RPE), and retinal function while countering oxidative stress, apoptosis, and vascular dysfunction in age-related conditions like age-related macular degeneration.
Bilateral Grade 3 Nuclear Cataracts with Corneal Arcus
BG3NC is driven by oxidative stress, crystallin protein aggregation, glycation, and age-related changes, while corneal arcus represents peripheral lipid deposition often linked to aging or dyslipidemia.
Peptides address regenerative and antioxidant defense, promote anti-glycation, enhance blood flow, reduce inflammation to support lens clarity, enhance tissue repair, reduce progression risk, and promote ocular health.
Cataracts
Cataracts are characterized by lens opacification due to crystallin protein aggregation, oxidative damage, and misfolding.
Polypeptides address cytoprotection, oxidative stress reduction, tissue integrity, endothelial function, protection against oxidative insults in ocular systems, free radical neutralization, regenerative signaling to counter lens oxidation, actin-binding structural stabilization and regeneration, cellular motility, actin sequestration, epithelial maintenance relevant to lens transparency, mitochondrial function, reduction of oxidative damage in lens cells, protein misfolding, crystallin aggregation, and suppression of cataract progression.
Glaucoma
Peptides address intraocular pressure, neuroprotection for retinal ganglion cells, enhanced aqueous humor outflow, anti-inflammatory and antimicrobial effects, antioxidant protection, optic nerve regeneration and tissue healing, improved vascular regulation, modulation of neuronal signaling, protection of retinal cells from oxidative damage in glaucoma, and alleviation of glaucoma symptoms by improving blood flow.
Retinal Degeneration
Retinal degeneration refers to a group of progressive disorders involving the loss of photoreceptors, retinal pigment epithelium (RPE), and associated neuronal cells, leading to impaired vision or blindness. Major forms include retinitis pigmentosa, age-related macular degeneration, and Stargardt disease.
Pathophysiology features chronic oxidative stress, mitochondrial dysfunction, chronic low-grade inflammation with microglial activation and cytokine dysregulation, programmed cell death, vascular leakage or abnormal angiogenesis, and disrupted visual cycle or retinoid metabolism, resulting in symptoms like night blindness, peripheral vision loss, central scotomas, and eventual severe visual impairment.
Polypeptides address degenerative mechanisms for multiaxis protection, preserving photoreceptors and RPE in models of detachment and degeneration, anti-inflammatory support, vasoprotective effects, mitigating inflammation-driven damage, vascular complications, tissue repair, reducing oxidative stress, apoptosis, recovery in laser-induced and stress-related retinal damage, stabilized neurotrophic signaling, photoreceptor survival, and counteracting multiple cell death pathways.
Diabetic Retinopathy
Diabetic Retinopathy is a progressive microvascular complication of diabetes mellitus, characterized by retinal vascular damage, including pericyte loss, blood-retinal barrier breakdown, capillary non-perfusion, pathological neovascularization, and macular edema, potentially leading to vision impairment or blindness; advanced stages involve proliferative changes and neurodegeneration.
Peptides address metabolic improvement, anti-inflammation, neuroprotection, anti-angiogenic effects, reduction of vascular permeability and oxidative stress, inhibition of angiogenesis, endothelial protection, autophagy support, and anti-apoptotic effects for retinal cells.
Eye Floaters I
Eye Floaters are perceived visual disturbances caused by shadows of vitreous opacities (collagen aggregates or debris) cast on the retina, often resulting from age-related vitreous syneresis, liquefaction, and posterior vitreous detachment.
Peptides support anti-glycation protection, vitreoretinal interface modulation, collagen aggregation inhibition, retinal neuroprotection, mitochondrial oxidative stress mitigation, cellular resilience, reducing oxidative damage in ocular tissues, normalizing protein synthesis in eye tissues, reducing symptomatic vitreous opacities, and protecting retinal neurons from age-related degenerative stress associated with vitreous changes
Eye Floaters II
Eye floaters are visual disturbances caused by collagen aggregates, debris, or liquefaction in the vitreous humor, often age-related or secondary to inflammation/oxidative stress.
Peptides support ocular healing and regeneration, anti-inflammation, antioxidant protection, collagen stabilization to potentially reduce opacities and support vitreous integrity, vitreous repair, enhancing cell migration, wound healing, anti-inflammatory effects in ocular surface disorders, tissue repair relevant to degenerative processes, neuroprotection, inflammation reduction without erythropoietic risks, and stabilizing vitreous structure against degeneration.
Macular Degeneration
Macular Degeneration addresses primarily age-related macular degeneration: dry/atrophic and neovascular/wet forms.
Peptides support neuroprotection, anti-apoptosis, tissue repair, anti-inflammation, anti-angiogenic effects, retinal tissue repair, counteracting ischemia, photoreceptor survival in retinal degeneration, attenuating apoptosis in age-related macular degeneration, reducing retinal degeneration, antimicrobial protection at the ocular surface, reducing oxidative stress in retinal cells, balancing immune responses in the retina, inhibiting abnormal vessel growth in wet AMD, retinal pigment epithelium function and prevent degeneration.
Optic Nerve Regeneration
Optic Nerve Regeneration encompasses therapeutic approaches to enhance retinal ganglion cell (RGC) survival and axon regrowth following traumatic injury, ischemia, or degenerative conditions such as glaucoma, countering inhibitory factors like myelin debris and glial scarring while boosting intrinsic growth mechanisms.
Peptides support neurotrophic enhancement, direct neuroprotection to RGCs and optic nerve fibers, reducing apoptosis, stimulating axon regeneration after optic nerve damage, promoting tissue repair, cell migration, anti-fibrotic effects supporting neural and ocular tissue regeneration, normalizing gene expression and protein synthesis in retinal ganglion and optic nerve cells for regenerative support, mitochondrial support, enhancing mitochondrial function and oxidative stress resistance, innate repair activation, reducing neuroinflammation and promote protective remodeling in optic nerve tissues, mitigating glial scarring and facilitate axon extension.
Hyperopia (Farsightedness) and Myopia (Nearsightedness)
Peptides address ocular growth regulation, scleral remodeling, anti-microbial and anti-inflammatory effects, tissue repair, regeneration, and integrity, mitochondrial function, immunomodulation, and antioxidant properties.
Emotional Balance
Peptides effectively manage stress, anxiety, and emotional responses, thereby promoting overall mental well-being. Emotional disruptions and imbalances can lead to conditions such as anxiety disorders, depression, or chronic stress. Peptides facilitate emotional balance by modulating neurotransmitter release (serotonin, dopamine, GABA), hormonal regulation (Hypothalamic-Pituitary-Adrenal axis via cortisol), neuropeptide signaling for social interaction, anxiety reduction, stress resilience, neuroprotection, anti-inflammatory effects, mood and pain-related emotions, and sleep regulation.
NOTE: Peptide programs were developed over eight years of research to support molecular-level frequency work. Peptide frequencies offer multitudes of benefits for the body. A particular peptide may be in a certain program for its medically researched and acknowledged benefits for a particular challenge; it may also help in many other areas of the body. If your body doesn’t require the benefit of a particular peptide in frequency form, that peptide will not do anything for you and will not have any negative effect.